Lymphoma typically occurs in multiple lesions and is sensitive to radiation therapy.[12] CD38 has been found to be highly expressed for some lymphoma such as MM.[25] The first anti‐CD38‐humanized mAb daratumumab was subsequently approved for the treatment of relapsed MM. This evidence concerns the gene CD38 and Miyoshi myopathy.